Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin for prevention of atrial fibrillation recurrence
NCT00579098Phase 4Completed
- Sponsor
- Mayo Clinic
- Start
- Dec 2007
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of atorvastatin in Atrial fibrillation (AFib), sponsored by Mayo Clinic. Started Dec 2007; status: completed.
02
Drugs
atorvastatin
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT00579098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00579098.